Evidence map›Paper›PMID 16439549›Full record

ArticleJournal of virology2006

Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells.

Wenjie Tan, Zheng Dong, Thomas A Wilkinson, Carlos F Barbas, Samson A Chow

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. IL-15 regulates susceptibility of CD4Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Article
  9. Sites of retroviral DNA integration: From basic research to clinical applications.Critical reviews in biochemistry and molecular biology · 2016
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wenjie TanDepartment of Molecular and Medical Pharmacology, Molecular Biology Institute, and UCLA AIDS Institute, UCLA School of Medicine, Los Angeles, CA 90095, USA.
Zheng Dong
Thomas A Wilkinson
Carlos F Barbas
Samson A Chow
Scripps Research Institute · US

Funding

Interdisciplinary Training in Virology and Gene TherapyT32AI060567 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WU, TING-TING · 2004 to 2018
$3.4M
Transcriptional Blockades of HIV-1R01GM065059 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI BARBAS, CARLOS F · 2003 to 2010
$2.8M
MOLECULAR MECHANISMS OF HIV1 DNA INTEGRATIONR01CA068859 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHOW, SAMSON A · 1995 to 2008
$2.5M
NCI NIH HHS CA68859NCI NIH HHS R01 CA068859NIAID NIH HHS T32 AI060567NIGMS NIH HHS GM065059NIGMS NIH HHS R01 GM065059
6 · The paper itself

Abstract

In vitro studies using fusion proteins consisting of human immunodeficiency virus type 1 integrase (IN) and a synthetic polydactyl zinc finger protein E2C, a sequence-specific DNA-binding protein, showed that integration of retroviral DNA can be biased towards a contiguous 18-bp E2C-recognition site. To determine whether the fusion protein strategy can achieve site-specific integration in vivo, viruses were prepared by cotransfection and various IN-E2C fusion proteins were packaged in trans into virions. The resulting viruses incorporated with the IN-E2C fusion proteins were functional and capable of performing integration at a level ranging from 1 to 24% of that of viruses containing wild-type (WT) IN. Two of the more infectious viruses, which contained E2C fused to either the N (E2C/IN) or to the C (IN/E2C) terminus of IN, were tested for their ability to direct integration into a unique E2C-binding site present within the 5' untranslated region of erbB-2 gene on human chromosome 17. The copy number of proviral DNA was measured using a quantitative real-time nested-PCR assay, and the specificity of directed integration was determined by comparing the number of proviruses within the vicinity of the E2C-binding site to that in the whole genome. Viruses containing IN/E2C fusion proteins had sevenfold higher preference for integrating near the E2C-binding site than those viruses containing WT IN, whereas viruses containing E2C/IN had 10-fold higher preference. The results indicated that the IN-E2C fusion protein strategy is capable of directing integration of retroviral DNA into a predetermined chromosomal region in the human genome.

Indexed as

Genome, HumanVirus IntegrationBinding SitesCell LineChromosomes, Human, Pair 17DNA-Binding ProteinsDNA, ViralGenes, erbB-2HIV-1HIV IntegraseHumansPolymerase Chain ReactionProvirusesRecombinant Fusion ProteinsDNA-Binding ProteinsDNA, ViralHIV IntegraseRecombinant Fusion Proteins

Identifiers

PMID16439549
PMCPMC1367172
OpenAlexW2142775272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.